Weekly Rundown: Gilead jumps into in vivo CAR T cell space
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Gilead has entered the in vivo CAR T cell space. This development marks a new area of focus for the company. The details and implications of this move are not specified.